Test of Propranolol for Severe Behaviors in Autism
Treatments studied
Part of Mental health clinical trials.
This study tests a medication called propranolol to see if it can reduce aggression and other severe behaviors in adolescents and adults with autism. It might be an option if you have frequent and serious challenging behaviors that other treatments haven't helped.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 40 years old.
- You must have a diagnosis of autism spectrum disorder.
- You must have severe challenging behaviors (like aggression or self-injury) that happen at least once a week and affect your safety or quality of life.
- You need a study partner (someone who knows you well) who can help report on your behaviors and safety at home.
- You must be able to swallow a capsule and have English as your primary language.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to measure how well different treatments work for young children with autism and intellectual disability who have challenging behaviors like aggression or self-injury. It may help you and your child find a treatment that reduces these behaviors and improves daily life.
This study tests whether deep brain stimulation can reduce severe self-injurious behaviors in children with autism. If standard treatments haven't worked, this approach may offer a new option.
This trial tests whether buspirone, a medication that helps with anxiety, can reduce anxiety in children and teens with autism. It is a 12-week study where participants receive buspirone or a placebo (a pill with no medicine) to see if it improves anxiety symptoms.
This trial tests whether adding oxytocin nasal spray to standard behavioral therapy can help reduce challenging behaviors in children with autism and intellectual disability. It aims to see if the treatment is safe and practical.
This trial tests whether deep brain stimulation, a surgical treatment that uses implanted electrodes to regulate brain activity, can reduce severe and persistent aggression in adults who have not improved with other treatments. It may offer a new option for people with schizophrenia or autism who experience aggressive behavior that is hard to control.
This trial tests a new cell-based treatment (called VGN-Ex05e) for young people with autism who have severe self-injury or aggression that hasn't improved with standard treatments. The treatment is given as a one-time injection into a specific area of the brain (nucleus accumbens) to help calm these behaviors.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.